跳至主要内容
临床试验/PACTR201802003063273
PACTR201802003063273尚未招募未知

Sulphadoxine/Pyrimethamine and Proguanil for malaria prophylaxis in Sickle Cell pregnancy: A Randomized Controlled Trial (SPICKLE TRIAL)

EDCTP0 个研究点目标入组 248 人开始时间: 2018年2月7日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
248

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 Year(s) 至 49 Year(s)(—)
性别
Female

入选标准

  • ¿Pregnant women of all gravidity confirmed as having HbSS genotype.
  • ¿Screened after 16 weeks or onset of quickening, both aparasitaemic and parasitaemic at first enrolment.
  • ¿Must give informed written consent.

排除标准

  • ¿Known adverse drug reaction to any of the two medications (Sulphadoxine/Pyrimethamine and Proguanil).
  • ¿Co-existing medical disorders that may alter immunity such as diabetes mellitus (DM) and human immunodeficiency virus infection (HIV).
  • ¿Multiple gestations.
  • ¿Presence of severe clinical malaria at booking.
  • ¿Less than 16 weeks gestational age for Sulphadoxine/Pyrimethamine (SP) group.
  • ¿Use of antimalarials within the last one week prior to booking.
  • ¿Refusal to give informed written consent.

研究者

发起方
EDCTP

相似试验